Literature DB >> 32360519

Dupilumab to treat severe atopic dermatitis in autosomal dominant hyper-IgE syndrome.

Georgios Sogkas1, Stefanie Hirsch2, Alexandra Jablonka2, Torsten Witte2, Reinhold E Schmidt2, Faranaz Atschekzei2.   

Abstract

Entities:  

Keywords:  Atopic dermatitis; Dupilumab; Eczema; HIES; Primary immunodeficiency; STAT3

Mesh：

Substances：

Year:  2020        PMID： 32360519     DOI： 10.1016/j.clim.2020.108452

Source DB:  PubMed          Journal:  Clin Immunol        ISSN： 1521-6616            Impact factor:   3.969


× No keyword cloud information.
  5 in total

1.  Diagnostic Yield and Therapeutic Consequences of Targeted Next-Generation Sequencing in Sporadic Primary Immunodeficiency.

Authors:  Georgios Sogkas; Natalia Dubrowinskaja; Katharina Schütz; Lars Steinbrück; Jasper Götting; Nicolaus Schwerk; Ulrich Baumann; Bodo Grimbacher; Torsten Witte; Reinhold E Schmidt; Faranaz Atschekzei
Journal:  Int Arch Allergy Immunol       Date:  2021-10-07       Impact factor: 2.749

Review 2.  Biologic Therapies for the Management of Cutaneous Findings in Genodermatoses: A Review.

Authors:  Tejas P Joshi; Hannah Y Wang; Prazwal Athukuri; Sarah Bohac; Morgan A Farr; Darien Hinson; Justin A Kahla; Nasim Khalfe; Dylan B McBee; Rachel Stroh; Nicole Walters; Vicky Ren
Journal:  Am J Clin Dermatol       Date:  2022-05-23       Impact factor: 6.233

Review 3.  STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions.

Authors:  Christo Tsilifis; Alexandra F Freeman; Andrew R Gennery
Journal:  J Clin Immunol       Date:  2021-05-01       Impact factor: 8.317

4.  Remission of eczema and recovery of Th1 polarization following treatment with Dupilumab in STAT3 hyper IgE syndrome.

Authors:  Caterina Matucci-Cerinic; Gianmaria Viglizzo; Carlotta Pastorino; Anna Corcione; Ignazia Prigione; Paola Bocca; Marta Bustaffa; Massimiliano Cecconi; Marco Gattorno; Stefano Volpi
Journal:  Pediatr Allergy Immunol       Date:  2022-04       Impact factor: 5.464

Review 5.  Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity.

Authors:  Georgios Sogkas; Faranaz Atschekzei; Ignatius Ryan Adriawan; Natalia Dubrowinskaja; Torsten Witte; Reinhold Ernst Schmidt
Journal:  Cell Mol Immunol       Date:  2021-04-01       Impact factor: 11.530
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.